Gary Ingenito - Jun 5, 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Med. & Reg. Officer
Signature
/s/ Gary Ingenito
Stock symbol
CPRX
Transactions as of
Jun 5, 2024
Transactions value $
-$972,000
Form type
4
Date filed
6/7/2024, 05:00 PM
Previous filing
Feb 16, 2024
Next filing
Aug 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $321K +80K +155.67% $4.01 131K Jun 5, 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$1.29M -80K -60.89% $16.16 51.4K Jun 5, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -80K -7.08% $0.00 1.05M Jun 5, 2024 Common Stock 80K $4.01 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Dr. Ingenito sold the shares on the open market to for personal reasons and to fund the exercise price and tax withholding of the exercise of the stock option, and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $16.11 to $16.27 per share.
F3 Options vested in three annual tranches beginning on January 2, 2019.